Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Anthelmintic Activity In Vivo of Epiisopiloturine against Juvenile and Adult Worms of Schistosoma mansoni

Full text
Author(s):
Show less -
Guimaraes, Maria A. [1] ; de Oliveira, Rosimeire N. [2] ; Veras, Leiz M. C. [1, 3] ; Lima, David F. [1, 3, 4] ; Campelo, Yuri D. M. [1, 3] ; Campos, Stefano Augusto [1] ; Kuckelhaus, Selma A. S. [5] ; Pinto, Pedro L. S. [6] ; Eaton, Peter [7] ; Mafud, Ana C. [8] ; Mascarenhas, Yvonne P. [8] ; Allegretti, Silmara M. [2] ; de Moraes, Josue [9] ; Lolic, Aleksandar [10] ; Verbic, Tatjana [10] ; Leite, Jose Roberto S. A. [1]
Total Authors: 16
Affiliation:
[1] Univ Fed Piaui, BIOTEC, Biotechnol & Biodivers Ctr Res, Parnaiba, Piaui - Brazil
[2] Univ Estadual Campinas, Inst Biol, Dept Anim Biol, Sao Paulo - Brazil
[3] Focal Point Fed Univ Piaui, RENORBIO, Grad Program Biotechnol, Teresina, Piaui - Brazil
[4] Fed Univ Sao Francisco Valley, Collegiate Acad Med, Paulo Afonso, BA - Brazil
[5] Univ Brasilia, Fac Med, Brasilia, DF - Brazil
[6] Adolfo Lutz Inst, Cent Lab, Sao Paulo - Brazil
[7] Univ Porto, Fac Sci, Dept Chem & Biochem, UCIBIO, REQUIMTE, P-4100 Oporto - Portugal
[8] Univ Sao Paulo, Grp Crystallog, Inst Phys Sao Carlos, Sao Paulo - Brazil
[9] Res Ctr Neglected Dis NPDN FACIG, Sao Paulo - Brazil
[10] Univ Belgrade, Fac Chem, Belgrade - Serbia
Total Affiliations: 10
Document type: Journal article
Source: PLoS Neglected Tropical Diseases; v. 9, n. 3 MAR 2015.
Web of Science Citations: 18
Abstract

Schistosomiasis is a serious disease currently estimated to affect more that 207 million people worldwide. Due to the intensive use of praziquantel, there is increasing concern about the development of drug-resistant strains. Therefore, it is necessary to search for and investigate new potential schistosomicidal compounds. This work reports the in vivo effect of the alkaloid epiisopiloturine (EPI) against adults and juvenile worms of Schistosoma mansoni. EPI was first purified its thermal behavior and theoretical solubility parameters charaterised. In the experiment, mice were treated with EPI over the 21 days post-infection with the doses of 40 and 200 mg/kg, and 45 days post-infection with single doses of 40, 100 and 300 mg/kg. The treatment with EPI at 40 mg/kg was more effective in adult worms when compared with doses of 100 and 300 mg/kg. The treatment with 40 mg/kg in adult worms reduced parasite burden significantly, lead to reduction in hepatosplenomegaly, reduced the egg burden in faeces, and decreased granuloma diameter. Scanning electron microscopy revealed morphological changes to the parasite tegument after treatment, including the loss of important features. Additionally, the in vivo treatment against juvenile with 40 mg/kg showed a reduction of the total worm burden of 50.2%. Histopathological studies were performed on liver, spleen, lung, kidney and brain and EPI was shown to have a DL50 of 8000 mg/kg. Therefore EPI shows potential to be used in schistosomiasis treatment. This is the first time that schistosomicidal in vivo activity of EPI has been reported. (AU)

FAPESP's process: 14/02282-6 - Structure-activity relationship studies about of Pilocarpus microphyllus (Rutaceae) alkaloid derivatives against Schistosoma mansoni
Grantee:Ana Carolina Mafud
Support Opportunities: Scholarships in Brazil - Post-Doctoral